Good morning :)
Place Order
Add to Watchlist

Vaishali Pharma Ltd

VAISHALI

Vaishali Pharma Ltd

VAISHALI
Health CarePharmaceuticals
SmallcapWith a market cap of ₹237 cr, stock is ranked 2,352
High RiskStock is 3.95x as volatile as Nifty
18.220.22% (-0.04)
18.220.22% (-0.04)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹237 cr, stock is ranked 2,352
High RiskStock is 3.95x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹237 cr, stock is ranked 2,352
High RiskStock is 3.95x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
286.395.55
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.276.550.51%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Vaishali Pharma Limited is a pharmaceutical company engaged in dealing in pharmaceutical formulations, active pharmaceutical ingredient (APIs), surgical products, veterinary supplements, and herbal and nutraceutical products

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 2.76%, vs industry avg of 9.03%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.04% to 0.02%

Lower than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 0%, vs industry avg of 15.28%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue69.8964.9069.4277.0762.2655.5877.6171.8988.3193.03
Raw Materialssubtract62.0753.9460.6167.7850.9945.8663.5457.1071.7589.77
Power & Fuel Costsubtract0.000.000.000.000.000.000.000.000.00
Employee Costsubtract1.561.592.042.131.271.191.361.301.40
Selling & Administrative Expensessubtract0.002.382.972.152.621.944.064.283.44
Operating & Other expensessubtract2.532.59-0.650.964.312.13-0.03-2.398.03
Depreciation/Amortizationsubtract0.370.280.250.270.440.430.460.500.510.50
Interest & Other Itemssubtract3.373.102.852.662.562.632.492.262.271.68
Taxes & Other Itemssubtract0.030.330.550.420.050.361.702.240.210.25
EPS-0.010.090.010.000.000.100.380.630.070.08
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2018

Annual Report Unavailable

Investor Presentation

Jun 1PDF
Feb 26PDF
FY 2019

Annual Report Unavailable

FY 2020

Annual Report Unavailable

Investor Presentation

May 28PDF
FY 2021

Annual Report Pending

Investor Presentation

Aug 6PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Vaishali Pharma Ltd339.575.55
Sun Pharmaceutical Industries Ltd45.346.470.75%
Cipla Ltd31.214.800.82%
Torrent Pharmaceuticals Ltd65.3815.800.88%

Price Comparison

Compare VAISHALI with any stock or ETF
Compare VAISHALI with any stock or ETF
VAISHALI
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Increased Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 4.97%

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding26.32%0.00%0.00%0.00%73.67%

May 2024

Jun 2024

Jul 2024

Sep 2024

Shareholding History

Dec '23MarMayJunJulSep0.00%0.00%0.02%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

VAISHALI has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Corporate
Vaishali Pharma schedules board meeting

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 10 October 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Vaishali Pharma to conduct board meeting

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 3 October 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Vaishali Pharma to hold board meeting

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 28 August 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Vaishali Pharma to convene AGM

Vaishali Pharma announced that the 17th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Vaishali Pharma standalone net profit rises 6.92% in the June 2024 quarter

Net profit of Vaishali Pharma rose 6.92% to Rs 1.70 crore in the quarter ended June 2024 as against Rs 1.59 crore during the previous quarter ended June 2023. Sales rose 34.72% to Rs 18.08 crore in the quarter ended June 2024 as against Rs 13.42 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales18.0813.42 35 OPM %13.0017.21 - PBDT2.392.24 7 PBT2.272.12 7 NP1.701.59 7 Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Vaishali Pharma to hold board meeting

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live

Stocks that will see action on March 2, 2023

1 year agoThe Hindu Businessline

Vaishali Pharma bags orders worth Rs 600 crore for purchase of antibiotic products

1 year agoThe Hindu Businessline

Vaishali Pharma standalone net profit rises 65.22% in the December 2022 quarter

1 year agoBusiness Standard

Stock market update: Stocks that hit 52-week highs on NSE in today’s trade

1 year agoEconomic Times